Q2 2022 Holdings
Filed 2022-08-16 | 78 holdings | $9.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| 2Seventy BIO Inc COM(TSVT*) | COMMON STOCK | 901384107 | $3.7K | 48 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $4.5K | 248 | 0.0% |
| Madrigal Pharmaceuticals(MDGL) | COM | 558868105 | $5.4K | 383 | 0.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $10.0K | 190 | 0.1% |
| Anaptysbio Inc COM(ANAB) | COM | 032724106 | $10.0K | 203 | 0.1% |
| Karuna Therapeutics Inc C | COM | 48576A100 | $12.4K | 1,567 | 0.1% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $14.0K | 535 | 0.1% |
| Prothena Corp PLC Usd0.01(PRTA) | COM | G72800108 | $15.0K | 407 | 0.2% |
| Beigene LTD Sponsored ADR(ONC) | Sponsored ADR | 07725L102 | $15.7K | 2,542 | 0.2% |
| Protagonist Therapeutics(PTGX) | COM | 74366E102 | $16.2K | 128 | 0.2% |
| Springworks Therapeutics | COM | 85205L107 | $16.3K | 401 | 0.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $17.2K | 2,683 | 0.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $19.5K | 985 | 0.2% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $20.0K | 4,713 | 0.2% |
| PTC Therapeutics Inc COM(PTCT) | COM | 69366J200 | $21.0K | 842 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $21.5K | 476 | 0.2% |
| Beam Therapeutics Inc COM(BEAM) | COM | 07373V105 | $23.5K | 910 | 0.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $23.7K | 14,010 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $24.0K | 1,242 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $25.5K | 774 | 0.3% |
| Biontech SE ADS(BNTX) | SPONSORED ADS | 09075V102 | $25.8K | 3,847 | 0.3% |
| Ascendis Pharma A/S Spons(ASND) | Sponsored ADR | 04351P101 | $29.4K | 2,733 | 0.3% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $31.5K | 1,576 | 0.3% |
| Intercept Pharmaceuticals(ICPTUSD) | COM | 45845P108 | $32.0K | 441 | 0.3% |
| Novocure Ltd(NVCR) | ORD SHS | G6674U108 | $32.0K | 2,224 | 0.3% |
| Apellis Pharmaceuticals I(APLS) | COM | 03753U106 | $32.5K | 1,470 | 0.3% |
| Crispr Therapeutics AG Co(CRSP) | NAMEN AKT | H17182108 | $34.2K | 2,078 | 0.4% |
| Denali Therapeutics Inc C(DNLI) | COM | 24823R105 | $38.0K | 1,118 | 0.4% |
| Alnylam Pharmaceuticals I(ALNY) | COM | 02043Q107 | $38.0K | 5,542 | 0.4% |
| Insmed Inc COM PAR $.01(INSM) | COM | 457669307 | $40.1K | 791 | 0.4% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $40.7K | 9,915 | 0.4% |
| Black Diamond Therapeutic | COM | 0920E3105 | $44.0K | 107 | 0.5% |
| Krystal Biotech Inc COM(KRYS) | COM | 501147102 | $45.0K | 2,955 | 0.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $46.1K | 1,703 | 0.5% |
| Illumina Inc COM(ILMN) | COM | 452327109 | $48.0K | 8,850 | 0.5% |
| Avadel Pharmaceuticals PL | Sponsored ADR | 05337M104 | $50.0K | 122 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $50.0K | 570 | 0.5% |
| Alkermes PLC SHS(ALKS) | SHS | G01767105 | $51.0K | 1,519 | 0.5% |
| Biogen Inc Common Stock(BIIB) | COM | 09062X103 | $52.0K | 10,606 | 0.5% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $57.0K | 602 | 0.6% |
| Genmab(GMAB) | SPONSORED ADS | 372303206 | $57.2K | 1,857 | 0.6% |
| Immunovant Inc COM(IMVT) | COM | 45258J102 | $60.0K | 233 | 0.6% |
| Ironwood Pharmaceuticals(IRWD) | COM | 46333X108 | $60.0K | 692 | 0.6% |
| Rocket Pharmaceuticals in(RCKT) | COM | 77313F106 | $63.0K | 868 | 0.7% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $63.2K | 3,603 | 0.7% |
| Seagen Inc COM(SGENUSD) | COM | 81181C104 | $65.6K | 11,607 | 0.7% |
| Hutchmed China Limited SP(HCM) | SPONSORED ADS | 44842L103 | $68.0K | 859 | 0.7% |
| Guardant Health Inc COM(GH) | COM | 40131M109 | $74.5K | 3,005 | 0.8% |
| ZAI LAB LTD ADR(ZLAB) | ADR | 98887Q104 | $79.0K | 2,736 | 0.8% |
| Biomarin Pharmaceutical I(BMRN) | COM | 09061G101 | $79.7K | 6,601 | 0.8% |